CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please consider our Risk Disclosure Notice and ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please consider our Risk Disclosure Notice and ensure that you fully understand the risks involved.

A2 Milk share price: UBS maintains buy rating heading into H1 results

UBS analysts remain bullish on a2 Milk’s prospects as we approach the IMF company’s half-year results.

A2 Milk share price in focus Source: Bloomberg

A2 Milk share price at a glance

It’s been a good week for a2 Milk (ASX: A2M) shareholders. In the last five sessions the A2M share price has risen a shade over 5%, closing out the week at $15.50 per share.

All up, this has proven to be quite a reversal of fortunes for the company; last November the stock hit a low of $11.31 per share.

Past price volatility aside, the investment bank UBS has today taken the chance to reiterate their 'buy' rating on a2 Milk. UBS has also retained their previously set share price target of NZ$17.00 per share.

The company is expected to release their first-half results on February 27.

Do you own a2 Milk shares? You can hedge your downside risk by trading CFDs now.

UBS: the new and old view

Recent data compiled by UBS looks to have reaffirmed the broker's already bullish stance on the IMF company.

Here it was noted that:

‘A2 Platinum share of best sellers was up ~570bp [...] year-on-year over 2QFY20 and pricing was ~steady, plus competitive behaviours should support CBEC share [and] Port export data: points to 1H20 volume growth of ~26% vs. UBSe +23% y/y, assuming steady h/h inventory.’

This is not to say questions around A2’s growth prospects don’t remain, with UBS analysts pondering three central questions that are likely to impact the company moving forward. Centrally, these questions are:

'What is a realistic long-term share of the China IMF market' for A2?, 'what level of profitability can A2M retain to achieve share aspirations'?, and ‘does CEO turnover suggest risk to the strategy?'.

In saying that, A2's long-term growth profile is a favourable one – according to UBS. Revenue and earnings are expected to grow significantly in the coming years, while margins are expected to remain stable.

Looking at the specifics, UBS posits that A2’s revenue will rise from NZ$1,670.2m in FY20e to NZ$2,732.3m in FY23e. Earnings are expected to climb in-step, with net earnings forecast to come in at NZ$346.5m in FY20e and NZ$579.7m in FY23e.

Earnings (EBIT) margins are also expected to remain stable over the coming years, according to UBS, currently expected to hit 29.5% in FY20e, 29.2% in FY21e, 28.7% in FY22e and 29.7% in FY23e.

Though UBS may be positive on A2M's outlook, this is not a view held by all brokers.

For example and at the other end of the spectrum, Citi analysts ultimately believe that over the medium-term A2M's margins will contract as Chinese IMF competition increases and as a 'shift to direct channels' occurs.

In saying that, Citi has moderated their bearish stance in recent times: just this week upgrading their rating from ‘sell’ to ‘neutral’ and upgrading their 12-month share price target from $12.30 to $14.85 on a2 Milk.

Ready to start hedging? Open an account with IG today to get started.

The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer.

Act on share opportunities today

Go long or short on thousands of international stocks with CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Take your position
  • See whether your hunch pays off

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform

See opportunity on a stock?

Don’t miss your chance. Log in to take your position.

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.